Answers are grounded in this paper and cite their sources.
Chronic lymphocytic leukemia (CLL) is the most common leukemia, accounting for 25% to 30% of all leukemia in the Western world. Generally, CLL is considered incurable—although readily controllable—with combination therapies, including purine analogues, monoclonal antibodies, and newer targeted agents, such as ibrutinib [1]. Furthermore, heterogeneous outcomes result from different prognostic features at diagnosis or during evolution of disease. However, long-term disease-free survival (DFS) is increasingly possible with hematopoietic cell transplantation (HCT).
No takes yet. Share an insight, caveat, or question.
Marcie Tomblyn (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: